The integration combines ChartSpan’s expertise in Chronic Care Management and Advanced Primary Care Management with Validic’s digital health platform. By unifying these capabilities, the company creates a streamlined conduit that transforms patient-generated data from wearables and clinical devices into immediate, actionable insights for healthcare providers. Christine Hawkins, CEO of ChartSpan, noted that the move is designed to move healthcare organizations away from snapshot-based decision-making toward high-precision clinical action.
Beyond enhancing existing services, the deal expands ChartSpan’s portfolio to include Validic’s established API infrastructure and device logistics tools. This allows the firm to serve a broader market, including payers, life sciences companies, and digital health innovators. According to Validic CEO Drew Schiller, the merger capitalizes on the belief that the most critical health indicators often exist outside clinical walls. Oppenheimer & Co. Inc. served as the financial advisor for Validic, while BIP Capital led the financing for ChartSpan.




Comments (0)
No comments yet. Be the first!